Abiopharma

🔍 Mottola Frank (Executive)

Company: SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Report Date: 2025-08-25

Detailed Transactions and Holdings:

• Acquired 14,000 shares of Common Stock at $12.98 per share (Direct)
  Date: 2025-08-25 | Code: M | equity_swap_involved: 0 | shares_owned_after: 29,496.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 14,000 shares of Common Stock at $44.51 per share (Direct)
  Date: 2025-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 15,496.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 14,000 shares of Employee Stock Option (Right to Buy) at $12.98 per share (Derivative)
  Date: 2025-08-25 | Code: M | Expires: 2026-03-01 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Includes an aggregate of 345 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
• F2: The Reporting Person exercised the options indicated herein and sold the underlying shares prior to the expiration of such options on March 1, 2026.
• F3: The option vests in four equal annual installments beginning on March 1, 2017.